Skip to main content
main-content

Cardiology

Cardiology

19-08-2019 | Diabetes | News | Article

Meta-analysis demonstrates cardioprotective effect of GLP-1 receptor agonists

Treatment with glucagon-like peptide receptor agonists reduces the risk for major adverse cardiovascular events among people with type 2 diabetes, indicate findings from a large meta-analysis.

08-08-2019 | Rheumatology | Highlight | Article

NSAIDs contribute ‘substantially’ to increased CVD risk in osteoarthritis

People with osteoarthritis have a significantly higher risk for developing cardiovascular disease than those without, and the use of nonsteroidal anti-inflammatory drugs mediates a considerable proportion of this association, researchers report.

06-08-2019 | Diabetes | News | Article

Support for metformin cardioprotective effect

Findings from the SAVOR-TIMI 53 trial suggest that metformin treatment reduces cardiovascular and all-cause mortality but not nonfatal cardiovascular disease events, but a meta-analysis points to wider benefits.

23-07-2019 | Rheumatology | News | Article

Low IGF1 levels predict CV risk in RA patients

Low levels of insulin-like growth factor 1 are associated with increased rates of cardiovascular events among women with rheumatoid arthritis, researchers report.

01-07-2019 | Rheumatology | News | Article

OA patients at increased risk for multiple comorbidities

People with osteoarthritis are significantly more likely than those without to have multiple comorbidities, particularly stroke, peptic ulcers, and the metabolic syndrome, show results of a systematic review and meta-analysis of observational data.

27-06-2019 | Oncology | News | Article

Chest radiation increases cardiac risk in NSCLC patients

Patients with locally advanced non-small-cell lung cancer have a high risk for major adverse cardiac events after radiotherapy that may warrant a reduction in cardiac radiation dose, study findings indicate.

06-06-2019 | Rheumatology | News | Article

Atherosclerotic plaque burden may aid CV risk prediction in psoriatic disease

Increased atherosclerotic plaque burden, as estimated by carotid ultrasound, is associated with an increased risk for cardiovascular events in patients with psoriatic disease, Canadian researchers report.

08-05-2019 | Diabetes | News | Article

Need for multiple risk factor control highlighted in comorbid diabetes, heart disease

People with diabetes and stable ischemic heart disease are more likely to have long-term survival when they have a greater number of risk factors controlled at prespecified therapeutic goals, research shows.

02-05-2019 | Diabetes | News | Article

Metformin may be cardioprotective in patients with coronary artery disease

Findings from the MET-REMODEL trial suggest that metformin treatment may aid regression of left ventricular hypertrophy among nondiabetic patients with coronary artery disease.

31-03-2019 | Oncology | News | Article

Abiraterone may raise mortality risk in men with prostate cancer, CVD

Among men initiating abiraterone acetate for advanced prostate cancer, the mortality risk may be higher for those with versus without pre-existing cardiovascular disease, suggests a real-world study presented at the AACR Annual Meeting 2019 in Atlanta, Georgia, USA.

27-03-2019 | Cardiovascular | News | Article

Cardiovascular autonomic neuropathy can be reversed in type 2 diabetes

Cardiovascular autonomic neuropathy is reversible in people with type 2 diabetes, report Korean researchers who found that age was the most important predictor of recovery.

22-03-2019 | Cardiovascular | News | Article

HIIT plus resistance training may have cardiovascular benefits in type 2 diabetes

A 1-year exercise intervention combining high-intensity interval training with resistance training may improve measures of cardiovascular risk among people with type 2 diabetes, suggests a secondary analysis of the D2FIT trial.

12-10-2018 | Breast cancer | News | Article

Endocrine therapy impacts cardiovascular risk in women with breast cancer

Long-term use of adjuvant endocrine therapy by women with a history of nonmetastatic breast cancer can significantly alter their risk for some types of cardiovascular disease, a meta-analysis shows.

11-10-2018 | Neurology | News | Article

Anticoagulants could stave off increased risk of dementia associated with AF

Study findings show an increased risk of dementia in older people with atrial fibrillation and support the use of anticoagulants to reduce the likelihood.

13-03-2018 | Oncology | News | Article

Data further highlight link between childhood cancer and long-term CVD risk

Young adult survivors of childhood cancer are at increased risk for cardiovascular disease, which develops earlier than in the general population, German study findings confirm.

02-01-2018 | Oncology | News | Article

Cardiovascular toxicity common with carfilzomib for multiple myeloma

Carfilzomib is associated with a high rate of clinically significant cardiovascular adverse events in patients with multiple myeloma, show results of a systematic review and meta-analysis.

11-12-2017 | Rheumatology | News | Article

High coronary plaque burden in PsA patients

Psoriatic arthritis is associated with accelerated coronary plaque formation independently of metabolic disease, according to results from a single-center study.

18-09-2017 | Rheumatology | News | Article

RA disease activity and severity play ‘important role’ in reducing CVD risk

Targeting factors such as inflammation and disease activity in patients with rheumatoid arthritis could help reduce their risk for cardiovascular disease, study findings suggest.

30-08-2017 | Rheumatology | News | Article

Ibuprofen associated with elevated blood pressure in patients with arthritis

Patients with osteoarthritis or rheumatoid arthritis who take ibuprofen are more likely to experience an increase in systolic blood pressure than those taking celecoxib, results of the PRECISION-ABPM study suggest.

28-07-2017 | Oncology | News | Article

Statin eligibility points to increased cancer risk

Individuals eligible for statins according to the 2013 American College of Cardiology/American Heart Association guidelines have a significantly increased risk for developing or dying of cancer compared with noneligible individuals, US researchers report.

Image Credits